Our glycomimetics drug candidates are new chemical entities that offer an innovative therapeutic strategy to potentially address current unmet medical needs among a wide spectrum of orphan disease conditions.
Our glycomimetics drug candidates are new chemical entities that offer an innovative therapeutic strategy to potentially address current unmet medical needs among a wide spectrum of orphan disease conditions.
Acute Myeloid Leukemia (AML)